bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript
Before we begin, let me review our safe harbor statement.
Bluebird Bio Inc. (BLUE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 6,239,541 | $7,986,612 | +83% | 0% |
| 2. | Palo Alto Investors William Leland Edwards | 4,560,171 | $5,837,019 | +37% | 0.65% |
| 3. | Tang Capital Management Kevin C. Tang | 2,500,000 | $3,200,000 | +48% | 0.33% |
| 4. | Partner Fund Management Christopher Medlock James | 2,042,651 | $2,614,593 | 0.12% | |
| 5. | Alyeska Investment Group Anand Parekh | 1,255,937 | $1,607,599 | -82% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $52.26 | 4,781 | Officer, Director | 17,186 | 2015-12-08 | Filing | |
| $51.25 | 4,901 | Officer, Director | 12,405 | 2015-12-08 | Filing | |
| $85.00 | 1,176 | Director | 1,176 | 2014-12-19 | Filing | |
| $85.00 | 2,352 | Director | 5,293 | 2014-12-19 | Filing | |
| $34.00 | 2,941 | Director | 2,941 | 2014-07-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.97 | 3,834 | 121,006 | 2024-06-03 | Filing | ||
| $1.53 | 6,770 | 118,368 | 2024-03-01 | Filing | ||
| $1.53 | 6,095 | 279,998 | 2024-03-04 | Filing | ||
| $1.53 | 4,573 | 124,840 | 2024-03-04 | Filing | ||
| $0.90 | 2,714 | 129,413 | 2024-02-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,865,719 | $19,134,692 | 0% | |
| 2. | 8,983,001 | $12,396,541 | 0% | |
| 3. | 8,775,379 | $12,110,023 | 0% | |
| 4. | 8,077,697 | $11,147,222 | 0.36% | |
| 5. | 5,687,334 | $7,848,521 | 0% |
News See All
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this time all participants are in a listen-only mode.
5 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 5 best medical stocks to buy under $10.
5 Best 52-Week Low Stocks To Buy Now
Goldman Sachs recently said in its Americas Retail report for 2024 that retailers that offer ideas in "categories that consumers continue to prioritize" could gain in the year.
bluebird bio, Inc. (NASDAQ:BLUE) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the bluebird bio Third Quarter 2023 Results Conference Call.
5 Best Affordable Stocks To Buy Under $5
In this article, we discuss 5 best affordable stocks to buy under $5.
11 Best High Short Interest Stocks To Buy Now
In this piece, we will take a look at the 11 best high short interest stocks to buy now.
bluebird bio, Inc. (NASDAQ:BLUE) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the bluebird bio Second Quarter Results and Commercial Launch Progress Call. At this time, all participants are in a listen-only mode.
5 Best NASDAQ Penny Stocks to Buy
In this article, we discuss 5 best NASDAQ penny stocks to buy.
12 Cheap Healthcare Stocks to Buy in 2023
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
Billionaire Hedge Funds
